Promega builds plant to produce regulated products

Published: 29-Aug-2011
Manufacturing Analysis

Including sample preparation systems and reagents

Promega builds plant to produce regulated products
Promega Corporation, based in Madison, Wisconsin, US, has held a ground-breaking ceremony for a new cGMP facility to support business growth and customers who need FDA-regulated molecular biology products. These include sample preparation systems and reagents, which are part of diagnostic and medical tests sold by human diagnostic test providers.

The 260,000ft2 (24,150m2) facility will require an additional 100 people in the next five years. Most of the building will be dedicated to fixed and flexible manufacturing areas. It will also house a customer experience centre for training, laboratory demonstrations and conferences.

‘This building is our next step in expanding our product supply capabilities worldwide,’ said ceo Bill Linton.

Plans include a number of sustainable practices, including geothermal heating and cooling, dark sky compliant lighting, prairie restoration, bio-retention ponds for storm water run off among other sustainable features and construction practices.

Promega Corporation provides solutions and technical support to the life sciences industry. Its 2,000 products enable scientists worldwide to advance their knowledge in genomics, proteomics, cellular analysis, molecular diagnostics and human identification.

See more

You may also like

Analysis
Countable Labs and Promega to facilitate end-to end biological sample preparation and rare variant detection

Countable Labs and Promega to facilitate end-to end biological sample preparation and rare variant detection

Read more
Joint offering creates state-of-the-art workflow uniting Promega’s fast and reliable nucleic acid extraction instrumentation with Countable Labs’ accurate and easy-to-use Countable PCR technology to deliver accuracy across research

Trending Articles

  1. FDA escalates action against Dabur India over systemic data-integrity and cGMP failures The US FDA has issued a warning letter to Dabur India following an inspection that identified falsified records, missing laboratory data, inadequate cleaning and process validation and weaknesses in quality-unit oversight, saying the company's response failed to address the systemic nature of the deficiencies
  2. Roller compaction: stable, continuous production for oral solid dosage forms PCI’s David O’Connell examines how dry granulation supports sensitive formulations, improves powder handling and enables the controlled and scalable manufacture of granules for sachets, capsules and tablets
  3. Thermo Fisher Scientific launches new general purpose centrifuges with natural refrigerant cooling New X2 and S2 Series centrifuges combine precise performance with improved sustainability for research, biopharma and clinical laboratories
  4. DNA Script and GE Healthcare awarded $26m ARPA-H funding to scale cell-free DNA bioproduction The pair will combine DNA Script's EDS technology with GE HealthCare's DNA scaling technology to create a faster, more flexible manufacturing process for cell-free DNA as the use of personalised and time-sensitive genetic medicines grows
  5. Lonza delivered strong H1 2026 performance across all business platforms and upgrades full-year 2026 margin outlook In H1 2026, Lonza delivered sales of CHF 3.4 billion with +16.0% CER sales growth

Upcoming event

CPhI Milan

6–8 October 2026 | Exhibition | Fiera Milano, Italy See all

You may also like

Analysis
Countable Labs and Promega to facilitate end-to end biological sample preparation and rare variant detection

Countable Labs and Promega to facilitate end-to end biological sample preparation and rare variant detection

Joint offering creates state-of-the-art workflow uniting Promega’s fast and reliable nucleic acid extraction instrumentation with Countable Labs’ accurate and easy-to-use Countable PCR technology to deliver accuracy across research
Ingredients
Promega unveils cellular target engagement technology

Promega unveils cellular target engagement technology

TarSeer BRETSA platform enables early-stage studies for difficult proteins in drug discovery
Manufacturing
Promega opens new Shanghai facility

Promega opens new Shanghai facility

Provides additional r&d and cGMP manufacturing capabilities
Manufacturing
Edwards cryogenic portfolio now available globally

Edwards cryogenic portfolio now available globally

Bringing cryogenic cooling and vacuum technologies together in one integrated portfolio for customers worldwide
Manufacturing
SCHOTT Pharma launches EVERIC lyo & amber vials for light-sensitive ADCs

SCHOTT Pharma launches EVERIC lyo & amber vials for light-sensitive ADCs

Featuring the well-known EVERIC® lyo coating, EVERIC® lyo & amber is designed for lyophilised, light-sensitive antibody-drug-conjugates (ADCs). It offers reliable light protection at the primary packaging level, already during the fill-and-finish process. EVERIC amber is the first specialty vial for highly light-sensitive medications that simultaneously meets regulatory light transmission requirements in the EU, the U.S., and Japan
You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing
Portable gas detection in the pharmaceutical sector

Portable gas detection in the pharmaceutical sector

Gas safety is a critical consideration in the pharmaceutical sector. Hazardous gases and airborne contaminants are common by-products of manufacturing processes … and employers must control worker exposure in accordance with relevant legislation and industry standards
Manufacturing
New legal duties for QPs in decentralised manufacturing

New legal duties for QPs in decentralised manufacturing

In this clip, Dr. Peter Gough explains that QPs will be responsible for supervising decentralised activities, conducting regular audits, carrying out periodic on-site visits, confirming GMP compliance to regulatory authorities and notifying changes that may affect quality or safety
Subscribe now